Catherine A. Sohn - 06 Feb 2025 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ Greg Weaver, as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
06 Feb 2025
Net transactions value
$0
Form type
4
Filing time
07 Feb 2025, 16:05:14 UTC
Previous filing
30 Jan 2025
Next filing
18 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Stock Options (option to buy) Award $0 +18,600 $0.000000 18,600 06 Feb 2025 Common Stock, par value $0.0001 18,600 $6.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option shall vest as follows: (i) 50% on July 15, 2025, (ii) 25% on September 30, 2025 and 25% on December 31, 2025, subject to the reporting person's continued service through the applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney